The short answer
Rare cancers are a quarter of all cancer cases but each one is uncommon. That produces slow diagnosis, thin evidence, few trials, long journeys and a specific kind of loneliness.
NCI defines a rare cancer as one affecting fewer than 40,000 people a year in the US; UK and EU definitions use fewer than 6 cases per 100,000 people per year.
Rare cancers collectively account for around a quarter of all cancer cases and around a quarter of cancer deaths.
For many rare tumors there is no standard of care, and recommendations rest on case series and expert consensus rather than randomised trials.
Fewer trials exist because patients are geographically dispersed and research funding is lower; the trial-design threshold in Europe is fewer than 2 cases per 100,000 a year.
Choose how you want to understand this
The full explanation.
What "rare" actually means
The National Cancer Institute defines a rare cancer as one affecting fewer than 40,000 people a year in the United States. Cancer Research UK reports a different measure in the UK and EU. Experts there use an incidence threshold of fewer than 6 cases per 100,000 people per year. When designing clinical trials, they use a stricter cut-off of fewer than 2 per 100,000. By these definitions all childhood cancers are rare.
The collective figure is the part most people are not told. Rare cancers together make up around a quarter of all cancer cases and around a quarter of cancer deaths. Rare cancer as a category is common. Any single rare cancer is not. That mismatch drives almost everything else that follows.
Why the diagnosis took so long
Rare tumors produce symptoms that are unusual, or that look like something harmless. So they get investigated later. The pathology is harder as well. A general pathologist may see a given rare tumor once in a career. Confirming the diagnosis can need specialist review, extra immunohistochemistry or molecular testing, and advice from colleagues at other hospitals or in other countries. Cancer Research UK lists exactly this sequence as a reason rare cancers take longer to diagnose.
The treatment plan comes from the diagnosis. So expert pathology review is usually the single most valuable step available. Asking for it is standard practice for rare tumors. It is not a challenge to the first pathologist.
No standard of care, and what to ask instead
Standards of care are built from randomised trials, and randomised trials need patients. Some tumors are diagnosed in only a few hundred people a year worldwide. For those, the evidence has often never been generated. Recommendations get assembled from case series, registry data and expert consensus. Two specialists can therefore give different advice, while both reason carefully from thin evidence.
The useful question is not "what is the standard treatment." It is "what is this recommendation based on, and how confident are you." A clinician who answers that honestly is giving you more than one who produces false certainty.
Fewer trials, and further to travel
Cancer Research UK sets out why trials are scarcer. Patients are spread out geographically. Few hospitals see enough cases to run a study. Research funding follows larger populations. What exists is often a basket trial, which recruits by molecular feature rather than tumor type. Other options are a natural history study, or an early-phase study at a single center. NCI's MyPART network runs a natural history study for rare solid tumors in children and adults. It also holds rare tumor clinics at the NIH Clinical Center.
Travel is a recognized burden. Referral to a center that sees the tumor type routinely can mean hundreds of miles, over and over. Ask whether the specialist center will plan treatment while a local service delivers it.
The specific loneliness
Support groups fill with people who have common cancers and cannot follow the conversation. Nobody in the infusion suite has heard of your diagnosis. You spell the name each time you say it, including to clinicians. Online searching returns case reports rather than information written for patients. Survival figures come from forty people. People say "at least it's treatable" with no reference point for whether that is true. Cancer Research UK states plainly that people with rare cancers can feel isolated, and may never meet anyone else with the same type.
Some routes exist against that. Attending a specialist center gathers patients in one place and raises the chance of meeting someone. Most rare tumor types have a disease-specific foundation or a patient registry. These are the fastest way to reach both current evidence and other patients. In the UK, Cancer52 is an alliance representing rare and less common cancer charities. In Europe, the EURACAN reference network links specialist centers. Ask your team to name the foundation or registry for your specific diagnosis. That is a reasonable request.
Sources
Words to know
Tap any term to see what it means.
Common questions
What counts as a rare cancer?
Definitions differ by region. The National Cancer Institute uses fewer than 40,000 people diagnosed per year in the United States. Cancer Research UK reports that UK and EU experts use fewer than 6 cases per 100,000 people per year, with a lower threshold of fewer than 2 per 100,000 used when designing clinical trials. All childhood cancers are rare by these definitions.
Why is there no standard treatment for my cancer?
Standards of care are built from randomised trials, and randomised trials need enough patients. For tumors diagnosed in a few hundred people a year, that evidence usually does not exist. Recommendations are instead built from case series, registry data and expert consensus, which is why two specialists can disagree while both reasoning honestly.
Is a second opinion on the pathology worth it?
For rare tumors it is routine rather than adversarial. Diagnosis often depends on features a general pathologist may rarely encounter, and specialist centers frequently consult colleagues at other hospitals or in other countries. Since the treatment plan follows from the diagnosis, confirming the diagnosis first is the higher-leverage step.
How do I find anyone else with my diagnosis?
Disease-specific foundations and patient registries are the usual route, and many exist for individual rare tumor types. Specialist centers also concentrate patients, so attending one increases the chance of meeting others. Cancer Research UK notes explicitly that people with rare cancers may not know anyone else with their type.
Do I have to travel for treatment?
Often, at least for the initial assessment and planning. Cancer Research UK lists travel to a specialist hospital as a recognized burden of rare cancer care. Some centers will plan treatment remotely and let local services deliver it, which is worth asking about directly.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer ExplainedSources last checked: 2026-07-30 what this meansLast updated: 2026-08-10Next planned review: 2028-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share